Peak Processing Limited (PKP), an ASX-listed company,, formerly Althea Group Holdings Limited, operates as an FMCG organisation focused on the manufacturing, sales and distribution of THC beverages. The company develops products that comply with regulatory requirements and are intended for adult consumers in regulated markets, including the United States and Canada.
| ASX Code | PKP |
| Website | http://www.peakprocessing.com |
| Industry/Sector | Pharmaceuticals |
| Market Cap ($M) | 22 |
| PKP Share Price | $0.017 |
| Day High | $0.017 |
| Day Low | $0.017 |
| Last Close | $0.017 |
| PKP Share Price Movement | - ( No change ) |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Peak Processing Limited (PKP) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$4.14 | -$0.70 | -80.20% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$14.01 | -$3.70 | -4.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$13.73 | -$3.90 | -2.00% | 0.00 | 0.00 | 0.00% | 0.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Clarity Pharmaceuticals Ltd (CU6) | $866M | 0.3002 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Neuren Pharmaceuticals Limited (NEU) | $2,151M | -0.7857 | 0.0743 | 1.2000 | 72.9265 | 67.8800 | 30.8545 | 0.00% | 0.00% | 0.00% |
| Peak Processing Limited (PKP) | $24M | -0.8016 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | -24.30 | 0.00 |
| Market | 0.31 | 12.90 | 1.13 | 0.59 |
| Sector | 0.45 | 28.10 | 2.50 | 1.92 |
| Name | Position | Start Date |
|---|---|---|
| Mr Barry Katzman | Interim CEO, Managing Director | 3 Dec 2025 |
| Mr Matt John Adams | Non-Executive Director | 17 Feb 2025 |
| Mr Manik Pujara | Non-Executive Director, Non-Executive Chairman | 6 Oct 2025 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 30 Jun 2026 | ADAMS, Matt | Buy | Direct Shares | 300,000 | $1.000 | $300,000.000 |
| 29 Jun 2026 | PUJARA, Manik | Issued | Indirect Shares | 4,000,000 | $0.017 | $68,000.000 |
| 29 Jun 2026 | PUJARA, Manik | Issued | Indirect Shares | 4,000,000 | $0.017 | $68,000.000 |
See all changes in directors' interest & trades for Peak Processing Limited (PKP) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| Brian Mbesha | Chief Financial Officer |
| Adam John Gallagher | Company Secretary |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Peak Processing Limited (PKP). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 122,000,000 (14.43%) | Adman Lanes Pty Ltd |
| 60,044,720 (7.10%) | Joshua Michael Fegan |
| Date | Event |
|---|---|
| 26 February 2027 | Report (Interim) |
| 29 September 2026 | Report (Annual) |
| 28 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.